Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin ≥ 100 mg/m2

M. G. Kris, R. A. Clark, L. B. Tyson, W. F. Hahne, K. M.W. Pisters, R. J. Gralla

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin ≥ 100 mg/m<sup>2</sup>'. Together they form a unique fingerprint.

Medicine & Life Sciences